AD is characterized by deposition of β-amyloid plaques and phosphorylated tau (p-tau)-positive neurofibrillary tangles in patient brains with neuronal loss, synaptic dysfunction and gliosis [56, 57]. The gene discussed is MAPT; the disease is Alzheimer disease.